KPV · CAS 13147-31-4
KPV 10mg
KPV (Lys-Pro-Val) is a C-terminal tripeptide of alpha-MSH with potent anti-inflammatory activity at MC1R and MC3R. Extensive IBD model data showing mucosal protection, reduced NF-kB activation, and colonic epithelial repair. 99.0% HPLC purity.
Shop This CompoundFor laboratory research use only. Not for human consumption. Not FDA-approved for any use.
Vial & Storage Profile — KPV 10mg
- Vial Size
- 10mg
- Form
- Lyophilized Powder
- Purity
- 99.0% HPLC
- CAS
- 13147-31-4
- Storage
- -20C long-term
Mechanism of Action — KPV
MC1R and MC3R agonism in intestinal epithelial cells and macrophages suppresses NF-kB signaling, reduces pro-inflammatory cytokine production (TNF-a, IL-6, IL-1b), and promotes mucosal barrier integrity.
Common Researcher Questions — KPV 10mg
How does KPV relate to BPC-157 for gut research?+
KPV primarily targets mucosal inflammation via MC1R/MC3R with strong IBD data. BPC-157 targets angiogenesis and mucosal integrity via VEGFR2/NO. They address gut health through complementary mechanisms.
